论文信息 - A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia - 字舞流文

A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia

G. Pond | M. Moore | J. Wright | W. Stadler | E. Winquist | G. Gomez-Abuin | P. Degendorfer